A business in context

EW research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-31 · 0001225208-26-007408

  2. 4 · Ownership change

    Report date 2026-08-28 · 0001225208-26-007377

  3. 8-K · Current report

    Report date 2026-08-25 · 0001099800-26-000048 · Items 5.02

  4. 4 · Ownership change

    Report date 2026-08-26 · 0001225208-26-007335

  5. 4 · Ownership change

    Report date 2026-08-26 · 0001225208-26-007332

  6. 4 · Ownership change

    Report date 2026-08-11 · 0001225208-26-007065

  7. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001099800-26-000043

  8. 4 · Ownership change

    Report date 2026-07-30 · 0001225208-26-006853

  9. 4 · Ownership change

    Report date 2026-07-28 · 0001225208-26-006777

  10. 4 · Ownership change

    Report date 2026-07-27 · 0001225208-26-006743

  11. 8-K · Current report

    Report date 2026-07-23 · 0001099800-26-000038 · Items 2.02,9.01

  12. 8-K · Current report

    Report date 2026-05-07 · 0001099800-26-000028 · Items 5.02,5.07,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001099800-26-000026

  14. 8-K · Current report

    Report date 2026-05-02 · 0001099800-26-000023 · Items 5.02,7.01

  15. 8-K · Current report

    Report date 2026-04-23 · 0001099800-26-000021 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-05-07 · 0001099800-26-000015

  17. 10-K · Annual report

    Report date 2025-12-31 · 0001099800-26-000009

  18. 8-K · Current report

    Report date 2026-02-10 · 0001099800-26-000006 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2026-01-09 · 0001099800-26-000002 · Items 7.01,9.01

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001099800-25-000062

  21. 8-K · Current report

    Report date 2025-10-30 · 0001193125-25-258662 · Items 5.02,7.01,9.01

  22. 8-K · Current report

    Report date 2025-10-30 · 0001099800-25-000059 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-08-19 · 0001099800-25-000056 · Items 8.01,9.01

  24. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001099800-25-000048

  25. 8-K · Current report

    Report date 2025-08-06 · 0001099800-25-000046 · Items 7.01,9.01

  26. 8-K · Current report

    Report date 2025-07-21 · 0001193125-25-164527 · Items 5.02

  27. 8-K · Current report

    Report date 2025-07-24 · 0001099800-25-000037 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-05-08 · 0001099800-25-000026 · Items 5.02,5.07,9.01

  29. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001099800-25-000023

  30. 8-K · Current report

    Report date 2025-04-23 · 0001099800-25-000020 · Items 2.02,9.01

  31. DEF 14A · Proxy statement

    Report date 2024-12-31 · 0001099800-25-000013

  32. 10-K · Annual report

    Report date 2024-12-31 · 0001099800-25-000005

  33. 8-K · Current report

    Report date 2025-02-11 · 0001099800-25-000003 · Items 2.02,9.01

  34. SC 13G · Ownership disclosure

    0000902219-24-000388

  35. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001099800-24-000086

  36. 8-K · Current report

    Report date 2024-10-24 · 0001099800-24-000084 · Items 2.02,9.01

  37. SC 13G/A · Ownership disclosure

    0000932471-24-000173

  38. 8-K · Current report

    Report date 2024-09-03 · 0001099800-24-000082 · Items 7.01,9.01

  39. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001099800-24-000078

  40. 8-K · Current report

    Report date 2024-07-24 · 0001099800-24-000069 · Items 2.02,7.01,8.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 19 transaction rows19SGrant / award: 31 transaction rows31AExercise / conversion: 24 transaction rows24MTax / exercise payment: 25 transaction rows25FGift: 8 transaction rows8G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

107 matching transaction rows. Showing 51–100.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-08
2026-05-08
Chopra DaveenF · Tax / exercise payment
Disposed
Common Stock1141.082.76
2026-05-08
2026-05-08
Bruls AnnetteF · Tax / exercise payment
Disposed
Common Stock84.082.76
2026-05-07
2026-05-11
Markowitz WayneF · Tax / exercise payment
Disposed
Common Stock264.083.2
2026-05-07
2026-05-11
Markowitz WayneA · Grant / award
Acquired
Common Stock5200.00.0
2026-05-07
2026-05-11
Markowitz WayneA · Grant / award
Acquired
Performance Rights
Derivative security
5200.00.0
2026-05-07
2026-05-11
Markowitz WayneA · Grant / award
Acquired
Employee Stock Option (Right to Acquire)
Derivative security
26400.00.0
2026-05-07
2026-05-11
Zovighian Bernard JA · Grant / award
Acquired
Common Stock43800.00.0
2026-05-07
2026-05-11
Zovighian Bernard JF · Tax / exercise payment
Disposed
Common Stock4153.083.2
2026-05-07
2026-05-11
Zovighian Bernard JA · Grant / award
Acquired
Performance Rights
Derivative security
43800.00.0
2026-05-07
2026-05-11
Zovighian Bernard JA · Grant / award
Acquired
Employee Stock Option (Right to Acquire)
Derivative security
245300.00.0
2026-05-07
2026-05-08
BOBO DONALD E JRA · Grant / award
Acquired
Common Stock7850.00.0
2026-05-07
2026-05-08
BOBO DONALD E JRF · Tax / exercise payment
Disposed
Common Stock831.083.2
2026-05-07
2026-05-08
BOBO DONALD E JRA · Grant / award
Acquired
Performance Rights
Derivative security
7850.00.0
2026-05-07
2026-05-08
BOBO DONALD E JRA · Grant / award
Acquired
Employee Stock Option (Right to Acquire)
Derivative security
44000.00.0
2026-05-07
2026-05-08
Ullem Scott B.F · Tax / exercise payment
Disposed
Common Stock1373.083.2
2026-05-07
2026-05-08
Lippis Daniel J.F · Tax / exercise payment
Disposed
Common Stock309.083.2
2026-05-07
2026-05-08
Lippis Daniel J.A · Grant / award
Acquired
Common Stock7850.00.0
2026-05-07
2026-05-08
Lippis Daniel J.A · Grant / award
Acquired
Performance Rights
Derivative security
7850.00.0
2026-05-07
2026-05-08
Lippis Daniel J.A · Grant / award
Acquired
Employee Stock Option (Right to Acquire)
Derivative security
39900.00.0
2026-05-07
2026-05-08
Dahl Andrew M.A · Grant / award
Acquired
Common Stock3020.00.0
2026-05-07
2026-05-08
Dahl Andrew M.A · Grant / award
Acquired
Common Stock3985.00.0
2026-05-07
2026-05-08
Dahl Andrew M.A · Grant / award
Acquired
Employee Stock Option (Right to Acquire)
Derivative security
6745.00.0
2026-05-07
2026-05-08
Chopra DaveenA · Grant / award
Acquired
Common Stock9675.00.0
2026-05-07
2026-05-08
Chopra DaveenF · Tax / exercise payment
Disposed
Common Stock674.083.2
2026-05-07
2026-05-08
Chopra DaveenA · Grant / award
Acquired
Employee Stock Option (Right to Acquire)
Derivative security
49100.00.0
2026-05-07
2026-05-08
Chopra DaveenA · Grant / award
Acquired
Performance Rights
Derivative security
9675.00.0
2026-05-07
2026-05-08
Bruls AnnetteA · Grant / award
Acquired
Common Stock6650.00.0
2026-05-07
2026-05-08
Bruls AnnetteA · Grant / award
Acquired
Performance Rights
Derivative security
6650.00.0
2026-05-07
2026-05-08
Bruls AnnetteA · Grant / award
Acquired
Employee Stock Option (Right to Acquire)
Derivative security
33700.00.0
2026-05-05
2026-05-05
Ullem Scott B.F · Tax / exercise payment
Disposed
Common Stock11131.082.91
2026-05-05
2026-05-05
Ullem Scott B.M · Exercise / conversion
Acquired
Common Stock13000.059.26
2026-05-05
2026-05-05
Ullem Scott B.M · Exercise / conversion
Disposed
Employee Stock Option (Right to Acquire)
Derivative security
13000.00.0
2026-05-05
2026-05-05
Zovighian Bernard JG · Gift
Acquired
Common Stock523.00.0
2026-05-05
2026-05-05
Zovighian Bernard JG · Gift
Disposed
Common Stock523.00.0
2026-05-04
2026-05-04
Lippis Daniel J.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1019.083.98
2026-05-04
2026-05-04
Lippis Daniel J.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock1019.059.26
2026-05-04
2026-05-04
Lippis Daniel J.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (Right to Acquire)
Derivative security
1019.00.0
2026-05-03
2026-05-05
Ullem Scott B.F · Tax / exercise payment
Disposed
Common Stock620.083.98
2026-05-03
2026-05-05
Zovighian Bernard JF · Tax / exercise payment
Disposed
Common Stock515.083.98
2026-05-03
2026-05-04
Lippis Daniel J.
10b5-1 checkbox reported
F · Tax / exercise payment
Disposed
Common Stock252.083.98
2026-05-03
2026-05-04
Chopra DaveenF · Tax / exercise payment
Disposed
Common Stock282.083.98
2026-05-03
2026-05-04
BOBO DONALD E JRF · Tax / exercise payment
Disposed
Common Stock469.083.98
2026-05-01
2026-05-04
Lippis Daniel J.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock1019.059.26
2026-05-01
2026-05-04
Lippis Daniel J.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock19.083.99
2026-05-01
2026-05-04
Lippis Daniel J.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1000.082.99
2026-05-01
2026-05-04
Lippis Daniel J.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (Right to Acquire)
Derivative security
1019.00.0
2026-04-09
2026-04-09
Ullem Scott B.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8324.079.79
2026-04-09
2026-04-09
Ullem Scott B.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock13000.059.26
2026-04-09
2026-04-09
Ullem Scott B.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4676.080.5
2026-04-09
2026-04-09
Ullem Scott B.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (Right to Acquire)
Derivative security
13000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001099800Edwards Lifesciences Corp

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Edwards Lifesciences · alias · wikidata
  • Edwards Lifesciences (Switzerland) · alias · wikidata
  • CVG CONTROLLED INC · former SEC name · 1999-12-08 to 2000-01-21
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$5.44B$5.79B
2023-12-31$5.01B$5.49B
2022-12-31$4.46B$5.09B
2021-12-31$5.23B$6.45B
2020-12-31$4.39B$5.66B
2019-12-31$4.35B$5.68B
2018-12-31$3.72B$4.95B
2017-12-31$3.44B$4.68B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗